The FDA has approved ‘breakthrough’ drug Keytruda (pembrolizumab) to fight lung cancer. Keytruda was tested on nearly non-small cell lung cancer patients in a largest study published till date using immunotherapy for lung cancer treatment.
The FDA has granted the...
Keywords: FDA, Keytruda, FDA, lung cancer drug
Read More